Continue to meet or exceed healthcare partners’ expectations by providing on-time test results approximately 92 percent of the time.
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...